-
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
on behalf of the T2B! immunity against SARS-CoV-2 study group, 1 Dec 2023, In: BMC Infectious Diseases. 23, 1, 332.Research output: Contribution to journal › Article › Academic › peer-review
-
Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod
van Kempen, Z. L. E., van Dam, K. P. J., Keijser, J. B. D., Stalman, E. W., Kummer, L. Y. L., Strijbis, E. M. M., Steenhuis, M., ten Brinke, A., van Ham, S. M., Kuijpers, T., Rispens, T., Eftimov, F., Wieske, L. & Killestein, J., 9 Nov 2023, (E-pub ahead of print) In: MULTIPLE SCLEROSIS JOURNAL. p. 13524585231207761Research output: Contribution to journal › Article › Academic › peer-review
-
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
Wieske, L., Stalman, E. W., van Dam, P. J. K., Kummer, L. Y., Steenhuis, M., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G., van der Kooi, A., Raaphorst, J., Löwenberg, M., Takkenberg, B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., & 38 others , 1 Jun 2023, In: Annals of the rheumatic diseases. 82, 6, p. 883-885 3 p., ard-2022-223464.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications